Thus, the first objective of this study was to test whether chronic, intracerebroventricular (ICV) infusion of NaHS may alleviate rodent angiotensin II (Ang II)–induced HTN and reduce microglia cell counts in the PVN. The gene discussed is AGT; the disease is hypertensive disorder.